http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3326808-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9851be62d5e4b0e256c3759391036b3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2123-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0406 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
| filingDate | 1983-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf5c6c7f9ed96b20a605730ab25fbe7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e757614fb79d90e63d38d68473dc4408 |
| publicationDate | 1984-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-3326808-A1 |
| titleOfInvention | METHOD FOR PRODUCING HALOGEN-MARKED RADIOPHARMACA |
| abstract | The formation of covalent bonds between a solid, insoluble carrier (F) which has reactive groups, a bifunctional linker (B) and a soluble organic compound (M) which can be labelled with halogen results in a corresponding solid and insoluble product (F-B-M). This product is labelled with iodine-123 or bromine-77, the resulting product (F-B-M<*>) is cleaved with a non-toxic reagent, and the aqueous solution of the labelled compound (M<*>) is separated from the solid, insoluble remaining product (F-B) or (F). The process removes, especially when a kit developed therefor is used, the excess of iodination or bromination agent and the by-products of the reaction in a more simple and direct manner than in labelling methods hitherto disclosed. The labelled compounds are intended for use in nuclear medicine for diagnostic purposes. |
| priorityDate | 1982-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.